INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Corporate insider
KA

Khattar Jack A.

Director, President, CEOCIK 0001539937

EDGAR filingsOpen in network
Disclosed transactions15
Buys / sells0 / 0
Max Insider Score12
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
1.26M sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    SUPERNUS PHARMACEUTICALS, INC.Director, President, CEO · Nov 4, 2026
12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J
—
250.0K sh
Nov 2, 2026
Nov 4, 2026
traded Nov 2, 2026
+2d
SEC FORM 4

Evidence

12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
958.1K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
400.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
19.3K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
169.1K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
205.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
300.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
281.3K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
250.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
280.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
322.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
331.7K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
341.6K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
KA
Khattar Jack A.Director, President, CEO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
200.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence